# A Double-Blind Randomized Placebo-Controlled Trial of Orlistat for the Treatment of Nonalcoholic Fatty Liver Disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-double-blind-randomized-placebo-controlled-trial-of-orlistat-for-the-treatment/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shira Zelber‐Sagi,Ada Kessler,Eli Brazowsky,Muriel Webb,Yoav Lurie,M Espirito Santo,Moshe Leshno,Laurence M. Blendis,Zamir Halpern,Ran Oren |
| Citations | 317 |
| DOI | 10.1016/j.cgh.2006.02.004 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.cghjournal.org/article/S1542356506001443/pdf |
| OpenAlex ID | https://openalex.org/W2154075360 |
| PMID | 16630771 |
| Type | article |
| Year | 2006 |

## Paper authors

- [Moshe Leshno](https://scholariq.org/researchers/moshe-leshno/)

## Paper journal

- [Clinical Gastroenterology and Hepatology](https://scholariq.org/journals/clinical-gastroenterology-and-hepatology/)

## Paper primary topic

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Paper topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.